SARAS-CoV-2 Test

详情

COVID**9 IgG/IgM Rapid Test Cassette (Colloidal gold)
(Whole Blood/ Serum/Plasma)
【PRODUCT NAME]
COVID**9 IgG/IgM Rapid Test Cassette
【SPECIFICATION]
*5Tests/Kit
The COVID**9 IgG/IgM Test Cassette is a lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to COVID**9 in human whole blood, serum or plasma specimen.
The COVID**9 IgG/IgM Test Cassette (Whole Blood/Serum/ Plasma) is a qualitative membrane- based immunoassay for the detection of IgG and IgM antibodies to COVID**9 in whole blood, serum or plasma specimen. This test consists of two components, an IgG component and an IgM component. In the IgG component, anti-human IgG is coated in IgG test line region. During testing, the specimen reacts with COVID**9 antigen-coated particles in the test cassette. The mixture  then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-human IgG in IgG test line region, if the specimen contains IgG antibodies to COVID**9.  A colored line will appear in IgG test line region as a result of this. Similarly, anti-human IgM is coated in IgM test line region and if specimen contains IgM antibodies to COVID**9, the conjugate- specimen complex reacts with anti-human IgM. A colored line appears in IgM test line region as a result.
Therefore, if the specimen contains COVID*9 IgG antibodies, a colored line will appear in IgG test line region. If the specimen contains COVID**9 IgM antibodies, a colored line will appear in IgM test line region. If the specimen does not contain COVID**9 antibodies, no colored line will appear in either of the test line regions, indicating a negative result. To serve as a procedural control, a colored line will always appear in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.
The test contains anti-human IgM and anti-human IgG as the capture reagent,COVID**9 antigen as the detection reagent. A mouse anti-goat IgG is employed in the control line system.
1.For professionalin vitrodiagnostic use only. Do not use after expiration date. 2.Do not eat, drink or smoke in the area where the specimens or kits arehandled. 3.Do not use test if pouch is damaged.

• Handle all specimens as if they contain infectious agents. Observe established precautions against microbiological hazards throughout all procedures and follow the standard procedures for proper disposal of specimens.
• Wearprotectiveclothing such as laboratory coats,disposablegloves and eyeprotectionwhenspecimensare assayed.
• Please ensure that an appropriate amount of samples are used for testing. Too much or too  little sample size may lead to deviation of results.
• The used test should be discarded according to local regulations.8.Humidity and temperature can adversely affect results.

• Separate serum or plasma from blood as soon as possible to avoid hemolysis. Use only clear

• Testing should be performed immediately after the specimens have been collected. Do not leave the specimens at room temperature for prolonged periods. Serum and plasma specimens may be stored at **8°C for up to 7 days, for long term storage, serum/plasma specimens should be kept below **0°C. Whole blood collected by venipuncture should be stored at **8°C if the test is to be run within 2 days of collection. Do not freeze whole blood specimens. Whole blood collected by fingerstick should be tested immediately.
• Bring specimens to room temperature prior to testing. Frozen specimens must be completely

• If specimens are to be shipped, they should be packed in compliance with local regulations covering the transportation of etiological agents.
• EDTA K2, Heparin sodium, Citrate sodium and Potassium Oxalate can be used as the anticoagulant for collecting the specimen.